ATE131809T1 - Dreizyklische chinoline als antineoplastische wirkstoffe - Google Patents

Dreizyklische chinoline als antineoplastische wirkstoffe

Info

Publication number
ATE131809T1
ATE131809T1 AT90119985T AT90119985T ATE131809T1 AT E131809 T1 ATE131809 T1 AT E131809T1 AT 90119985 T AT90119985 T AT 90119985T AT 90119985 T AT90119985 T AT 90119985T AT E131809 T1 ATE131809 T1 AT E131809T1
Authority
AT
Austria
Prior art keywords
lower alkyl
group
quinolines
actives
antineoplastic
Prior art date
Application number
AT90119985T
Other languages
English (en)
Inventor
Daniel T Chu
Jacob J Plattner
Larry L Klein
Linus L Shen
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Application granted granted Critical
Publication of ATE131809T1 publication Critical patent/ATE131809T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C333/00—Derivatives of thiocarbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C333/02—Monothiocarbamic acids; Derivatives thereof
    • C07C333/06—Monothiocarbamic acids; Derivatives thereof having nitrogen atoms of thiocarbamic groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
    • C07D513/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Steroid Compounds (AREA)
AT90119985T 1989-10-23 1990-10-18 Dreizyklische chinoline als antineoplastische wirkstoffe ATE131809T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/425,536 US5071848A (en) 1989-10-23 1989-10-23 Tricyclic quinoline antineoplastic agents

Publications (1)

Publication Number Publication Date
ATE131809T1 true ATE131809T1 (de) 1996-01-15

Family

ID=23686982

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90119985T ATE131809T1 (de) 1989-10-23 1990-10-18 Dreizyklische chinoline als antineoplastische wirkstoffe

Country Status (11)

Country Link
US (1) US5071848A (de)
EP (1) EP0424802B1 (de)
JP (1) JPH03167191A (de)
AT (1) ATE131809T1 (de)
CA (1) CA2028246A1 (de)
DE (1) DE69024322T2 (de)
DK (1) DK0424802T3 (de)
ES (1) ES2083990T3 (de)
GR (1) GR3018961T3 (de)
IE (1) IE71688B1 (de)
PT (1) PT95646A (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030129186A1 (en) 2001-07-25 2003-07-10 Biomarin Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
JP2008519842A (ja) * 2004-11-11 2008-06-12 アキリオン ファーマシューティカルズ，インコーポレーテッド 抗感染剤としての８ａ，９−ジヒドロ−４ａ−ｈ−イソチアゾロ［５，４−ｂ］キノリン−３，４−ジオンおよび関連化合物
WO2006074317A1 (en) * 2005-01-05 2006-07-13 Achillion Pharmaceuticals, Inc. 1-thia-2,4a-diaza-cyclopenta[b]naphthalene-3,4-diones and related compounds as anti-infective agents
WO2006084053A1 (en) * 2005-02-02 2006-08-10 Achillion Pharmaceuticals, Inc. 8-n-substituted-2h-isothiazolo[5,4-b]quinolizine-3,4-diones and related compounds as antiinfective agents
KR20070107123A (ko) * 2005-02-16 2007-11-06 아칠리온 파르마세우티칼스 인코포레이티드 항-감염제들로서의 새로운 이소티아졸로퀴놀론들 및 관련화합물들
SI1889198T1 (sl) 2005-04-28 2015-02-27 Proteus Digital Health, Inc. Farma-informacijski sistem
DE602006017082D1 (de) 2005-07-27 2010-11-04 Achillion Pharmaceuticals Inc 8-methoxy-9h-isothiazoloä5,4-büchinolin-3,4-dione und verwandte verbindungen als antiinfektive mittel
EP2063905B1 (de) 2006-09-18 2014-07-30 Raptor Pharmaceutical Inc Behandlungen von lebererkrankungen durch verabreichung von konjugaten aus rezeptor-assoziierten proteinen
EP2082814B1 (de) 2008-01-25 2011-04-27 Mitsubishi Materials Corporation Reaktorreinigungsvorrichtung
DK2398500T3 (da) 2009-02-20 2019-05-13 2 Bbb Medicines B V Glutathion-baseret lægemiddelafgivelsessystem
NZ595448A (en) * 2009-04-03 2013-01-25 Achillion Pharmaceuticals Inc Hydroxythienoquinolones and related compounds as anti-infective agents
ES2942923T3 (es) 2009-05-06 2023-06-07 Laboratory Skin Care Inc Composiciones de administración dérmica que comprenden complejos de agente activo-partículas de fosfato de calcio y métodos de uso de las mismas
WO2011031745A1 (en) 2009-09-09 2011-03-17 Achaogen, Inc. Antibacterial fluoroquinolone analogs
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
CN115650913B (zh) * 2022-10-12 2024-03-01 北京中医药大学 醌式喹啉类化合物及其制备方法和用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4767762A (en) * 1985-12-23 1988-08-30 Abbott Laboratories Tricyclic quinoline and naphthyride antibacterials
US4880814A (en) * 1987-11-13 1989-11-14 Abbott Laboratories 7-cycloalkyl naphthyridines
JPH01160985A (ja) * 1987-12-17 1989-06-23 Otsuka Pharmaceut Co Ltd ベンゾヘテロ環化合物
JPH01193275A (ja) * 1988-01-28 1989-08-03 Otsuka Pharmaceut Co Ltd ベンゾヘテロ環化合物
JP2681190B2 (ja) * 1988-04-13 1997-11-26 塩野義製薬株式会社 ピリドン系抗菌剤

Also Published As

Publication number Publication date
DE69024322T2 (de) 1996-10-31
IE903633A1 (en) 1991-04-24
DE69024322D1 (de) 1996-02-01
CA2028246A1 (en) 1991-04-24
DK0424802T3 (da) 1996-04-22
US5071848A (en) 1991-12-10
PT95646A (pt) 1991-09-13
EP0424802B1 (de) 1995-12-20
JPH03167191A (ja) 1991-07-19
IE71688B1 (en) 1997-02-26
EP0424802A2 (de) 1991-05-02
GR3018961T3 (en) 1996-05-31
ES2083990T3 (es) 1996-05-01
EP0424802A3 (en) 1992-05-06

Similar Documents

Publication Publication Date Title
ATE131809T1 (de) Dreizyklische chinoline als antineoplastische wirkstoffe
DE69926542D1 (de) Aminopyrazol derivate
NO863980D0 (no) Fremgangsmaate for fremstilling av kinazolinderivater.
ATE111453T1 (de) Heterocyclische oxy-phenoxy-essigsäurederivate und ihre verwendung als herbizide.
DE59005587D1 (de) Salicylaldehyd- und Salicylsäurederivate sowie deren Schwefelanaloge, Verfahren zu ihrer Herstellung und ihre Verwendung als Herbizide und Bioregulatoren.
FI905418A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten 4- tai 6-substituoitujen trimetyylipyrrolo/2,3-b/indolikarbamaattien valmistamiseksi
DK519985D0 (da) Quinoloncarboxylsyrederivater, fremgangsmaade til fremstilling deraf og antibakterielt middel indeholdende saadanne derivater
DK0526588T3 (da) Heterocykliske forbindelser, deres fremstilling og anvendelse
DK283984D0 (da) Benzodiazepinderivater og fremgangsmaade til fremstilling deraf
HU913218D0 (en) Process for the production of hydroxy-alkyl-kinoline-ethers and of medical preparations containing them
DK0385224T3 (da) Substituerede N-hydroxypyraxoler og fungicider der indeholder disse forbindelser
SE8300580D0 (sv) Substituerade 1,3,4-tiadiazolo (3,2-a)pyrimidiner och forfarande for deras framstellning
ATE10370T1 (de) Benzothiazinderivate, verfahren zu ihrer herstellung und ihre verwendung.
FI912499A (fi) Pyrido/3,4-b/pyrrolo/1,2-e//1,4,5/ oxadiazepiner och daermed naerbeslaektade analoger, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
NO800033L (no) 4-aminopyridin, fremgangsmaate til deres fremstilling og legemiddel inneholdende disse
DE3774176D1 (de) Substituierte n-phenylpyridazon-derivate.
ATE121937T1 (de) Verwendung von 2h-1,2,4-benzothiadiazin-3(4h)- thion-1,1-dioxiden als antivirale arzneimittel.
HUT47293A (en) Process for producing pyrimido-oxazine derivatives
ATE17490T1 (de) Dithiino (1,4) (2,3-c) pyrrolderivate, ihre herstellung und diese enthaltende pharmazeutische zubereitungen.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee